PL308201A1

Applicationj of hialuronic acid and various forms thereof in preventing recurrent arteriostenosis

Abstract

For preventing animal tube wall and lower pipe wall of the narrow, to the alleviation animal treating effective amount and non-toxic quantity's hyaluronic acid or salt thereof and equivalent, the interleukin-11, derivatives, compound and ester, the hyaluronic acid connected, preventing the pipe wall of a narrow with the subunit.

Term

Term ended

Projected expiry passed 22 September 2013, 13 years ago.

267 members in 34 offices

This recordMember, by publication datePriority claim24 more offices are in the list below

Priority claims8

Priority claims
Document	Office	Kind	Date
2079205	Canada	A	1992-09-25
2079205	Canada	A	1992-09-25
9300388	Canada	W	1993-09-22
9300388	Canada	W	1993-09-22
922079205	–	–	–
CA9300388	–	–	–
CA19922079205	–	–	–
WO1993CA00388	–	–	–

Members267

Family members, oldest first
Document	Office	Kind
CA2042034A1	Canada	A1	1991-03-22
WO9104058A2	World Intellectual Property Organization (WIPO)	A2	1991-04-04
AU6433090A	Australia	A	1991-04-18
NO911952D0	Norway	D0	1991-05-21
CN1051503A	China	A	1991-05-22
IL95745D0	Israel	D0	1991-06-30
NO911952L	Norway	L	1991-07-05
HU907339D0	Hungary	D0	1991-08-28
ZA907564B	South Africa	B	1991-08-28
EP0445255A1	European Patent Office (EPO)	A1	1991-09-11
WO9104058A3	World Intellectual Property Organization (WIPO)	A3	1991-09-19
BR9006924A	Brazil	A	1991-12-10
AP175A	African Regional Intellectual Property Organization (ARIPO)	A	1992-04-03
KR920700697A	Republic of Korea	A	1992-08-10
JPH04504579A	Japan	A	1992-08-13
IN171745B	India	B	1992-12-26
IL104796D0	Israel	D0	1993-06-10
IL104797D0	Israel	D0	1993-06-10
CA2061566A1	Canada	A1	1993-08-21
CA2061703A1	Canada	A1	1993-08-21
WO9316732A1	World Intellectual Property Organization (WIPO)	A1	1993-09-02
WO9316733A1	World Intellectual Property Organization (WIPO)	A1	1993-09-02
SK11093A3	Slovakia	A3	1993-09-09
SK11193A3	Slovakia	A3	1993-09-09
AU3488893A	Australia	A	1993-09-13
AU3488993A	Australia	A	1993-09-13
ZA931174B	South Africa	B	1993-09-16
MX9300904A	Mexico	A	1993-10-01
MX9300905A	Mexico	A	1993-10-01
CN1078388A	China	A	1993-11-17
IL107087D0	Israel	D0	1993-12-28
HUT64699A	Hungary	A	1994-02-28
AU5227493A	Australia	A	1994-03-03
CN1084064A	China	A	1994-03-23
CA2079205A1	Canada	A1	1994-03-26
HU9303282D0	Hungary	D0	1994-03-28
HU9303283D0	Hungary	D0	1994-03-28
WO9407505A1	World Intellectual Property Organization (WIPO)	A1	1994-04-14
ZA937068B	South Africa	B	1994-04-18
AU4812693A	Australia	A	1994-04-26
MX9305887A	Mexico	A	1994-05-31
NO943044D0	Norway	D0	1994-08-17
CN1092654A	China	A	1994-09-28
FI943789A	Finland	A	1994-10-03
NO943044L	Norway	L	1994-10-19
EP0626863A1	European Patent Office (EPO)	A1	1994-12-07
EP0626864A1	European Patent Office (EPO)	A1	1994-12-07
KR950700085A	Republic of Korea	A	1995-01-16
KR950700086A	Republic of Korea	A	1995-01-16
NO951122D0	Norway	D0	1995-03-23
NO951122L	Norway	L	1995-03-23
HU9500857D0	Hungary	D0	1995-05-29
EP0656213A1	European Patent Office (EPO)	A1	1995-06-07
LTIP1582A	Lithuania	A	1995-06-26
EP0661981A1	European Patent Office (EPO)	A1	1995-07-12
PL308201A1This record	Poland	A1	1995-07-24
JPH07506812A	Japan	A	1995-07-27
JPH07507054A	Japan	A	1995-08-03
WO9526193A1	World Intellectual Property Organization (WIPO)	A1	1995-10-05
AU6422294A	Australia	A	1995-10-17
IN175918B	India	B	1995-10-28
CA2122519A1	Canada	A1	1995-10-30
CA2122551A1	Canada	A1	1995-10-30
HUT70440A	Hungary	A	1995-10-30
WO9529683A1	World Intellectual Property Organization (WIPO)	A1	1995-11-09
WO9530423A2	World Intellectual Property Organization (WIPO)	A2	1995-11-16
LT3545B	Lithuania	B	1995-11-27
AU2300895A	Australia	A	1995-11-29
AU2402395A	Australia	A	1995-11-29
EP0445255B1	European Patent Office (EPO)	B1	1995-12-06
IL114914D0	Israel	D0	1995-12-08
AT131068T	Austria	T	1995-12-15
ATE131068T1	Austria	T1	1995-12-15
WO9530423A3	World Intellectual Property Organization (WIPO)	A3	1995-12-21
HU211689A9	Hungary	A9	1995-12-28
HU211698A9	Hungary	A9	1995-12-28
HU211823A9	Hungary	A9	1995-12-28
AP448A	African Regional Intellectual Property Organization (ARIPO)	A	1996-01-18
DE69024039D1	Germany	D1	1996-01-18
HU211953A9	Hungary	A9	1996-01-29
CZ66295A3	Czechia	A3	1996-02-14
ES2080837T3	Spain	T3	1996-02-16
CA2131130A1	Canada	A1	1996-03-01
TW271401B	Taiwan Province of China	B	1996-03-01
DK0445255T3	Denmark	T3	1996-03-04
WO9606622A1	World Intellectual Property Organization (WIPO)	A1	1996-03-07
AP475A	African Regional Intellectual Property Organization (ARIPO)	A	1996-03-08
AP476A	African Regional Intellectual Property Organization (ARIPO)	A	1996-03-18
AU3159595A	Australia	A	1996-03-22
ZA957223B	South Africa	B	1996-04-01
DE69024039T2	Germany	T2	1996-06-13
AU670117B2	Australia	B2	1996-07-04
JPH08506797A	Japan	A	1996-07-23
EP0661981B1	European Patent Office (EPO)	B1	1996-08-07
AT141054T	Austria	T	1996-08-15
ATE141054T1	Austria	T1	1996-08-15
HUT73637A	Hungary	A	1996-08-28
CN1130532A	China	A	1996-09-11
DE69303931D1	Germany	D1	1996-09-12
CA2145605A1	Canada	A1	1996-09-28

Showing 100 of 267

Applicationj of hialuronic acid and various forms thereof in preventing recurrent arteriostenosis

Abstract

Term

Priority claims8

Members267

Numbers

Titles

Classification